C
N
E
I
L
E
A
B
R SITE VISIT 27
range, is a pure Ceramide NP solution that addresses the decrease in natural ceramide levels within the skin. Designed for use is face and hair serums, as well as face and body creams, it replenishes and restores the skin barrier and improves skin hydration, texture and appearance.
Biotechnology ambitions Cerafy products align with the focus of Syensqo’s Renewable Materials and Biotechnology Growth Platform. Syensqo sees a €1.5bn market opportunity by 2030 by transforming feedstock into valuable molecules through biotechnology.
These include turning sugars, lignin, fatty acids, carbon dioxide and biogas into proteins, polymers and surfactants via microbes and enzymes. “It’s quite complex,” says Leroy. “First, it’s about the microorganism. You want it to be a super-producer. You can do this by different ways like genetic engineering to stimulate organisms to adapt to specific environments. “Then, there is fermentation, which could
be feeding microrganisms with sugar or oil, to produce a broth from which you extract the substance of interest within the cell of the microorganism. All this requires extraction,
separation and purification process expertise.” Such expertise can be found in Korea, where
Syensqo partners with Ewha Womans University in Seoul, giving it access to a strong pool of talent to improve its scaled-up manufacturing processes. Syensqo can also call on biotech engineering expertise in the US via a Ginkgo (formerly Zymergen) laboratory in Cambridge, Massachusetts acquired in 2023. A Paris lab, meanwhile, supports application
work, such as testing the skin care or hair care benefits of ceramides and other technologies. The Lyon R&I facility supports the whole Syensqo group on biotech processes, including fermentation, extraction, separation and purification. The Lyon facilities include a genetic engineering lab that develops new or evolving microbiological strains. The main goal is to increase the performance of a particular strain by optimising the fermentation process and making the product with fewer impurities. It upscales the processes from a lab setting
to a pilot plant via a stainless steel bioreactor, which in turn – when everything is tested and verified – allows it to be ready to make the step up to industrial scale fermentation. The Lyon centre seems certain to accelerate
Syensqo’s development of efficacious and eco- friendly solutions in keeping with its mantra of ‘Advancing Humanity’.
PC
T
G
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114
